Busch Matthew C. 4
4 · AMGEN INC · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Amgen (AMGN) VP/CAO Matthew Busch Pays Tax Withholding on 327 Shares
What Happened Matthew C. Busch, Vice President, Finance & Chief Accounting Officer of Amgen, had 327 shares disposed on March 16, 2026 to satisfy a tax liability (Form 4 code F). The shares were valued at $366.21 each for a total of approximately $119,751. This was a withholding/tax payment related to equity compensation (routine), not an open-market sale.
Key Details
- Transaction date: 2026-03-16; filing date: 2026-03-18 (timely).
- Shares involved: 327 shares disposed/withheld at $366.21 per share (total ≈ $119,751).
- Shares owned after transaction: Not reported in the provided filing.
- Footnote: 68 of the 327 shares are Dividend Equivalents (DEs) credited to unvested RSUs and paid out in shares per the company’s equity plan and dividend reinvestment rules.
- Transaction code: F (payment of exercise price or tax liability).
- No indication of a 10b5-1 plan, gift, or open-market trade in this filing.
Context This was a tax-withholding event associated with equity compensation (including DEs) and is typically administrative — shares were surrendered/withheld to cover taxes, not sold in the open market. Such withholding transactions are routine and do not by themselves signal insider buying or selling intent.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-03-16$366.21/sh−327$119,751→ 4,048 total
Footnotes (1)
- [F1]These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.